MEDIWELCOME (02159) Subsidiary Intends to Acquire 100% Equity in Hong Kong Universal Yicheng Wisdom Technology Development
Stock News
Jan 20
MEDIWELCOME (02159) announced that on January 20, 2026, a subsidiary of the company and a potential seller signed a non-legally binding memorandum of understanding regarding the possible acquisition of 100% of the equity in Hong Kong Universal Yicheng Wisdom Technology Development Limited, together with its subsidiaries collectively referred to as the "Target Group". The Target Group primarily provides artificial intelligence technology to global pharmaceutical and medical device companies, revolutionizing medical research and physician specialist training through its AI-powered specialized disease vertical models, while also utilizing its core Web3 blockchain technology to ensure data authenticity, security, and traceability.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.